Patterns of TH1/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate.

Hayrettin Tumani,Jan Kassubek,Mohammed Hijazi,Vera Lehmensiek,Alexander Unrath,Sigurd D. Süssmuth,Florian Lauda,Tamara Kapfer,Lubin Fang,Makbule Senel,Johannes Brettschneider

Patterns of TH1/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate.

2011

Hayrettin Tumani
Jan Kassubek
Mohammed Hijazi
Vera Lehmensiek
Alexander Unrath
Sigurd D. Süssmuth
Florian Lauda
Tamara Kapfer
Lubin Fang
Makbule Senel
Johannes Brettschneider

The patterns of Th1/Th2 cytokines in relapsing-remitting multiple sclerosis were analyzed to evaluate their relevance as biomarkers of therapy response to glatiramer acetate (GA). Serum interferon-γ (

Keywords:

Multiple sclerosis
Biomarker (medicine)
Medicine
Glatiramer acetate
Interferon
th2 cytokines
Immunology
therapy response
Diabetes mellitus
Anesthesia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations